Recent Developments in Dementia Treatment

The Food and Drug Administration (FDA) has recently granted full approval to a novel Alzheimer's treatment known as lecanemab. This medication has demonstrated the ability to moderately decelerate cognitive and functional decline in individuals with early-stage Alzheimer's disease. It received traditional approval from the US FDA for Alzheimer's disease treatment based on Phase 3 data derived from the Clarity AD clinical trial. Additionally, recent research suggests that older individuals with higher levels of triglycerides, a type of fat in the bloodstream, may experience a reduced risk of dementia and a slower cognitive decline over time when compared to those with lower triglyceride levels.

    Related Conference of Recent Developments in Dementia Treatment

    December 15-16, 2025

    20th Annual Congress on Neuroscience

    Paris, France
    January 29-30, 2026

    29th International Conference on Viral Infections & Virology

    Aix-en-Provence, France
    February 02-03, 2026

    7th Global Summit on Brain Disorders and Therapeutics

    Paris, France
    February 12-13, 2026

    8th World Conference on Neuroscience

    Singapore City, Singapore
    March 09-10, 2026

    7th International Conference on Neurologists

    Singapore City, Singapore
    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    May 18-19, 2026

    38th International conference on Mental Health and Psychiatry

    Aix-en-Provence, France
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands

    Recent Developments in Dementia Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in